The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S28-S33 , November 2004

PREDICTING PROSTATE CANCER BEHAVIOR USING TRANSCRIPT PROFILES

  • PETER S. NELSON

      Affiliations

    • Corresponding Author InformationCorrespondence: Divisions of Human Biology and Clinical Research, Mailstop D4-100, 1100 Fairview Ave. North, Seattle, Washington 98109

REFERENCES 

  1. Partin AW , Kattan MW , Subong EN , Walsh PC , Wojno KJ , Oesterling JE , et al.   Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update . JAMA . 1997;277:1445
  2. Kattan MW , Stapleton AM , Wheeler TM , Scardino PT . Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma . Cancer . 1997;79:528
  3. Kattan MW , Eastham JA , Stapleton AM , Wheeler TM , Scardino PT . A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer . J Natl Cancer Inst . 1998;90:766
  4. Kattan MW , Wheeler TM , Scardino PT . Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer . J Clin Oncol . 1999;17:1499
  5. Stamey TA , McNeal JE , Yemoto CM , Sigal BM , Johnstone IM . Biological determinants of cancer progression in men with prostate cancer . JAMA . 1999;281:1395
  6. Stamey TA , Yemoto CM , McNeal JE , Sigal BM , Johnstone IM . Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens . J Urol . 2000;163:1155
  7. Pound CR , Partin AW , Eisenberger MA , Chan DW , Pearson JD , Walsh PC . Natural history of progression after PSA elevation following radical prostatectomy . JAMA . 1999;281:1591
  8. Vassilikos EJ , Yu H , Trachtenberg J , Nam RK , Narod SA , Bromberg IL , et al.   Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up . Clin Biochem . 2000;33:115
  9. Partin AW , Yoo J , Carter HB , Pearson JD , Chan DW , Epstein JI , et al.   The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer . J Urol . 1993;150:110
  10. Schena M , Shalon D , Davis RW , Brown PO . Quantitative monitoring of gene expression patterns with a complementary DNA microarray . Science . 1995;270:467
  11. Alizadeh AA , Eisen MB , Davis RE , Ma C , Lossos IS , Rosenwald A , et al.   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling . Nature . 2000;403:503
  12. van 't Veer LJ , Dai H , van de Vijver MJ , He YD , Hart AA , Mao M , et al.   Gene expression profiling predicts clinical outcome of breast cancer . Nature . 2002;415:530
  13. Magee JA , Araki T , Patil S , Ehrig T , True L , Humphrey PA , et al.   Expression profiling reveals hepsin overexpression in prostate cancer . Cancer Res . 2001;61:5692
  14. Luo J , Duggan DJ , Chen Y , Sauvageot J , Ewing CM , Bittner ML , et al.   Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling . Cancer Res . 2001;61:4683
  15. Dhanasekaran SM , Barrette TR , Ghosh D , Shah R , Varambally S , Kurachi K , et al.   Delineation of prognostic biomarkers in prostate cancer . Nature . 2001;412:822
  16. Singh D , Febbo PG , Ross K , Jackson DG , Manola J , Ladd C , et al.   Gene expression correlates of clinical prostate cancer behavior . Cancer Cell . 2002;1:203
  17. Ramaswamy S , Ross KN , Lander ES , Golub TR . A molecular signature of metastasis in primary solid tumors . Nat Genet . 2003;33:49
  18. Hunter K , Welch DR , Liu ET . Genetic background is an important determinant of metastatic potential . Nat Genet . 2003;34:23
  19. Lifsted T , Le Voyer T , Williams M , Muller W , Klein-Szanto A , Buetow KH , et al.   Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression . Int J Cancer . 1998;77:640
  20. Chetcuti A , Margan S , Mann S , Russell P , Handelsman D , Rogers J , et al.   Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array . Prostate . 2001;47:132
  21. Chaib H , Cockrell EK , Rubin MA , Macoska JA . Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis . Neoplasia . 2001;3:43
  22. Luo J , Dunn T , Ewing C , Sauvageot J , Chen Y , Trent J , et al.   Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis . Prostate . 2002;51:189
  23. Welsh JB , Sapinoso LM , Su AI , Kern SG , Wang-Rodriguez J , Moskaluk CA , et al.   Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer . Cancer Res . 2001;61:5974
  24. Stamey TA , Warrington JA , Caldwell MC , Chen Z , Fan Z , Mahadevappa M , et al.   Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia . J Urol . 2001;166:2171
  25. Luo JH , Yu YP , Cieply K , Lin F , Deflavia P , Dhir R , et al.   Gene expression analysis of prostate cancers . Mol Carcinog . 2002;33:25
  26. Ernst T , Hergenhahn M , Kenzelmann M , Cohen CD , Bonrouhi M , Weninger A , et al.   Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue . Am J Pathol . 2002;160:2169
  27. LaTulippe E , Satagopan J , Smith A , Scher H , Scardino P , Reuter V , et al.   Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease . Cancer Res . 2002;62:4499
  28. Vanaja DK , Cheville JC , Iturria SJ , Young CY . Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression . Cancer Res . 2003;63:3877
  29. Best CJ , Leiva IM , Chuaqui RF , Gillespie JW , Duray PH , Murgai M , et al.   Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis . Diagn Mol Pathol . 2003;12:63
  30. Henshall SM , Afar DE , Hiller J , Horvath LG , Quinn DI , Rasiah KK , et al.   Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse . Cancer Res . 2003;63:4196

 Supported by National Cancer Institute SPORE Grant CA97186.

PII: S0022-5347(05)61304-3

doi: 10.1097/01.ju.0000142067.17181.68

The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S28-S33 , November 2004

Article Tools

* Image Usage & Resolution